Target Name: WDR27
NCBI ID: G253769
Review Report on WDR27 Target / Biomarker Content of Review Report on WDR27 Target / Biomarker
WDR27
Other Name(s): WDR27_HUMAN | WDR27 variant 1 | WD repeat-containing protein 27 | WD repeat domain 27 | WD repeat-containing protein 27 (isoform 1) | WD repeat domain 27, transcript variant 1

WDR27: Potential Drug Target Or Biomarker

WDR27 (WDR27_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, pancreas, and muscle. It is a member of the WDR27 family of proteins, which are known to play a role in the development and maintenance of various diseases, including diabetes.

WDR27 has been shown to be involved in a number of different biological processes in the body, including cell signaling, inflammation, and metabolism. It has also been shown to interact with a number of different proteins and drugs, making it a potential drug target or biomarker.

One of the most promising aspects of WDR27 is its potential as a drug target. WDR27 has been shown to play a role in the development and progression of a number of diseases, including type 2 diabetes, obesity, and neurodegenerative disorders. It has also been shown to interact with a number of different drugs, including those that are currently being used to treat these diseases.

In addition to its potential as a drug target, WDR27 has also been shown to be a potential biomarker for a number of different diseases. For example, studies have shown that levels of WDR27 are elevated in the brains of individuals with type 2 diabetes, and that these levels are associated with poor cognitive function and other negative health outcomes.

Another promising aspect of WDR27 is its potential to be used as a therapeutic agent. Studies have shown that WDR27 can be expressed and purified from human plasma, and that this expression can lead to significant increases in the levels of WDR27 in the body. This suggests that WDR27 could be used as a therapeutic agent to treat a number of different diseases, including those that are currently treated with drugs that interact with WDR27.

Overall, WDR27 is a protein that has the potential to be a drug target or biomarker, and further research is needed to fully understand its role in the body and its potential as a therapeutic agent.

Protein Name: WD Repeat Domain 27

The "WDR27 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about WDR27 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

WDR3 | WDR31 | WDR33 | WDR35 | WDR35-DT | WDR36 | WDR37 | WDR38 | WDR4 | WDR41 | WDR43 | WDR44 | WDR45 | WDR45B | WDR46 | WDR47 | WDR48 | WDR49 | WDR5 | WDR53 | WDR54 | WDR55 | WDR59 | WDR5B | WDR6 | WDR62 | WDR64 | WDR7 | WDR70 | WDR72 | WDR73 | WDR74 | WDR75 | WDR76 | WDR77 | WDR81 | WDR82 | WDR82P1 | WDR83 | WDR83OS | WDR86 | WDR86-AS1 | WDR87 | WDR88 | WDR89 | WDR90 | WDR91 | WDR93 | WDR97 | WDSUB1 | WDTC1 | WEE1 | WEE2 | WEE2-AS1 | WFDC1 | WFDC10A | WFDC10B | WFDC11 | WFDC12 | WFDC13 | WFDC2 | WFDC21P | WFDC3 | WFDC5 | WFDC6 | WFDC8 | WFDC9 | WFIKKN1 | WFIKKN2 | WFS1 | WHAMM | WHAMMP1 | WHAMMP2 | WHAMMP3 | WHRN | WIF1 | WIPF1 | WIPF2 | WIPF3 | WIPI1 | WIPI2 | WIZ | WLS | WNK1 | WNK2 | WNK3 | WNK4 | Wnt | WNT1 | WNT10A | WNT10B | WNT11 | WNT16 | WNT2 | WNT2B | WNT3 | WNT3A | WNT4 | WNT5A | WNT5B